Literature DB >> 2372006

Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT).

L H Kuller1, J Ockene, E Meilahn, K H Svendsen.   

Abstract

For men participating in the Multiple Risk Factor Intervention Trial, the authors evaluated the relation between the baseline forced expiratory volume in one second and lung cancer mortality among smokers between the third and tenth years of follow-up (1973-1974 to 1984). This measure of ventilatory function was a powerful predictor of lung cancer deaths, with rates that increased from 3.02 per 1,000 person-years in the lowest quintile of forced expiratory volume to 0.43 in the highest quintile. This relation was not weakened by adjustments for smoking dose, including number of cigarettes smoked per day, tar and nicotine content, duration of smoking, or age at onset of smoking. Nor was forced expiratory volume related to time between its determination and lung cancer death. If these observations can be verified in other studies, the forced expiratory volume in one second may identify smokers at very high risk of lung cancer and, hence, in need of more aggressive preventive approaches.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372006     DOI: 10.1093/oxfordjournals.aje.a115656

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  18 in total

1.  Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative.

Authors:  Ange Wang; FeiFei Qin; Haley Hedlin; Manisha Desai; Rowan Chlebowski; Scarlett Gomez; Charles B Eaton; Karen C Johnson; Lihong Qi; Jean Wactawski-Wende; Catherine Womack; Heather A Wakelee; Marcia L Stefanick
Journal:  Int J Cancer       Date:  2016-11-15       Impact factor: 7.396

Review 2.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

Review 3.  Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis.

Authors:  S Wasswa-Kintu; W Q Gan; S F P Man; P D Pare; D D Sin
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

4.  Decline in lung function and mortality: the Busselton Health Study.

Authors:  G Ryan; M W Knuiman; M L Divitini; A James; A W Musk; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  1999-04       Impact factor: 3.710

5.  Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers.

Authors:  Mark P Purdue; Laura Gold; Bengt Järvholm; Michael C R Alavanja; Mary H Ward; Roel Vermeulen
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

6.  Mortality from lung cancer among silicotic patients in Sardinia: an update study with 10 more years of follow up.

Authors:  P Carta; G Aru; P Manca
Journal:  Occup Environ Med       Date:  2001-12       Impact factor: 4.402

7.  Clinical measures, smoking, radon exposure, and risk of lung cancer in uranium miners.

Authors:  M M Finkelstein
Journal:  Occup Environ Med       Date:  1996-10       Impact factor: 4.402

8.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

9.  Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis.

Authors:  Georgios T Stathopoulos; Taylor P Sherrill; Dong-Sheng Cheng; Robert M Scoggins; Wei Han; Vasiliy V Polosukhin; Linda Connelly; Fiona E Yull; Barbara Fingleton; Timothy S Blackwell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205

Review 10.  Chronic obstructive pulmonary disease as a risk factor for lung cancer.

Authors:  Yuichi Takiguchi; Ikuo Sekine; Shunichiro Iwasawa; Ryota Kurimoto; Koichiro Tatsumi
Journal:  World J Clin Oncol       Date:  2014-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.